While this loss of first-phase insulin response is not unique to CF and has also been described in T2D [27, 28], it remains a prominent contributor to the pathophysiology of CFRD and these early abnormalities in insulin secretion may be more readily detected by a 1 hG [3, 17]. The gene discussed is INS; the disease is cystic fibrosis.